Advanta India Limited IPO Message Board (Page 2)

Hi...

I m nt telling to u for 1lacs but only minimum application, for take a chance...delivery base its too good

and also ketan gandhi does not know that current premium for icra is more than 250 rs now as sebi had made compulsory for ipo grading.if crisil is going up and up.then no doubt icra is 1000 rs stock.advanta is a bad buy.advanta is not in business which attract and maybe 400 was good price for it

Mr Ketan Gandhi if u r so confident please invest 1 lakh rs for it. its pretty sure that this is very expensively priced.will go down 20% .so apply for it u will get all shares and also 20% discount .all the best

Hi ALL
this avery good company.n is a subsidary of united phos. and one of the best company. advanta are very good.you all pls invest in both.premium of icra is just now 100 to 125.n advanta's premium Rs 70 to 80
you all submit application on last date of issue.
thanks and all the best
Ketan Gandhi

Hi Raj,
Don't worry.When the issue is not heavily subscribed they will allot in full.But tell me where will they credit the shares allotted.I will send them my dpid and client id details if you can give me details of the application.Pl expedite as the allotment will happen very soon.I need those shares badly to recover some losses.
All the best in your efforts at making in IPOs.

Advanta appears to be highly priced. There is every possibility of burning the fingers, as we burnt in other recent issue. It is better to avoid.

A 350 rs stock priced at 600 very bad who will buy at this price.we can easily get this share at 350-400 during listing.greedy promoters

Can anybody tell me if I have written wrong DP ID in my application form for an IPO then application can be rejected or will it process?
Thanks in advance

Mr Ureheja.

I agree with your views.

issue loks good , promoters are united phosphorous,
pricing is a bit on the risky side ,
wait for the last day and apply after qib quota is over .
this is my advise, pl tell if this is the right approach
or one can go for the issue

moneycontrol says ignore the IPO...
http://www.moneycontrol.com/india/news/ipoissuesopen/advantaindiaipoangelbroking/avoidadvantaind/market/stocks/article/273364

It is worth to apply Advanta @Rs 600-650 or wait for listing.

viral sha
what is grey market rate in Ahemdabad

Hi ! Advanta india is a good i.p.o. as 23rd march icra i.p.o has closed & now there is no chances for public to invest in advanta more so allotment chances is better. i compare to this company from monsanto. monsanto current price is above 1200/- so price fixed by the company is reasonable. invest more gain more. best of luck !!!

dont apply cm rating 43 definately in open market we can get below issue price. management is good but highly priced.

Advanta India - Adventurous pricing
CM RATING 43/100

A subsidiary of United Phosphorus (UPL), Advanta India, held by Advanta Netherlands Holdings, ITC-Zeneca, Syngenta, AgroTech Foods, and private equity investors at various stages, has developed a global portfolio of wide range of hybrid seed varieties including sunflower, rice, corn, rapeseed, mustard, sorghum, canola and oats.

Advanta India has three international subsidiaries in Australia, Thailand and Argentina. The international division of the Australian subsidiary caters to Asia, the Middle East, Africa and Latin America.

The subsidiaries outside India were earlier subsidiaries of Bio-win Corporation, a group company of the promoter group, United Phosphorous. Advanta Holdings B.V., a wholly owned subsidiary of Advanta India, acquired these subsidiaries from Bio-win at euro 95 million, or around Rs 556.52 crore, on 30 March 2006. Of this, Rs 227.44 crore is still outstanding. Advanta India will be using the IPO funds to pay off this liability.

Uniphos Seeds and Bio-Genetics Pvt Ltd (USBPL), one of the promoter group companies, got merged with Advanta India on 1 April 2006. Advanta India issued 33.77 lakh equity shares at par to the shareholders of USBPL: Jai Shroff and Vikram Shroff. USBPL was focused on developing, marketing and selling bio-engineered seeds for cotton crops licensed from Nath Seeds, an Indian company delisted by the stock exchanges.

Strengths:

1. Advanta India has well-developed brands and distribution network in the markets where it operates. The company owns and has access to a broad portfolio of proprietary germplasm, which is necessary for any seed company to gain competitive edge.

2. The company has been developing since the last 12 years a hybrid non-genetically modified sunflower variety in Argentina, named Sunsat. It will have the capability of lower bad cholesterol. Commercial production is slated to start in 2009.


Weaknesses:

1. Advanta India operates in a seasonal industry and is exposed to risks related to weather, disease and pests. Moreover, technology advances (like genetically modified seeds) are changing the dynamics of the industry. Besides, operations in many countries and crops make the performance highly unpredictable.

2. In the present form, the consolidated company has been in existence since March 2006. So comparable financial track record is not available for the past, except for the latest seven-month performance. The different consolidated entities have been growing individually at unexciting rates in the past few years. Not surprisingly, they have also changed hands often.


Valuation:

Advanta India has set a price band of Rs. 600 to Rs 650 per equity share of Rs 10 each, translating into a PE of 30.1x on the lower price band and 32.6x on the higher side of the price band, according to annualised EPS for the seven-month period ended October 2006 on post-issue equity of Rs. 16.83 crore. However, the actual EPS may be significantly different from the annnualised one due to seasonality in business (the impact of which is not ascertainable).

Monsanto India and Syngenta India, the listed Indian subsidiaries of MNCs, derive part of their revenue by selling hybrid and genetically modified seeds to Indian farmers. These companies are presently trading at PE of 21.6 on a trailing 12-month basis.

Hybrid seeds is not a high growth business and also prone to unpredictable fluctuations. Hence, the asking PE is very steep.

Now let;s wait for subscription figures from QIB;S to decide whether to apply or not.

Hi Mr Viral Shah,
Can you explain your previous mail...????
What do you suggest whether to invest or not to invest????

Comparison for company

Advanta post issue book value Rs 264.01
Syngenta book value Rs 124.50
Monsanto book value Rs 378.40

so advise current IPO price 650 invest open listing on 1050Rs. best of luck.

i have great news for Advanta for the seven-month period ended oct 31,2006 its reported revenue of Rs 237.91 Cr about 22 percent of revenues and net profit of Rs 35.. Cr amounting 15 percent margin. the compony expects the indian commercial seeds market to grow at a compound rate of about 10 percent over the next 4-5 years and to maintain its operating margins at about 18-19 percent annualy. For INVESTER, Advanta provides an opportunity to participate in the seeds business. i hope this issue one of the top most of highly on the yaer ended.

premium of I C R A is 150 so it will open at above490